{"id":"NCT00257608","sponsor":"Genentech, Inc.","briefTitle":"A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab Therapy With or Without Erlotinib After Completion of Chemotherapy With Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2014-11","completion":"2014-11","firstPosted":"2005-11-23","resultsPosted":"2016-03-15","lastUpdate":"2016-04-18"},"enrollment":1145,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"bevacizumab","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"erlotinib HCl","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase IIIb, multicenter, randomized, placebo-controlled trial to evaluate the safety and efficacy of chemotherapy+bevacizumab followed by bevacizumab+erlotinib versus bevacizumab+erlotinib placebo in subjects with locally advanced or metastatic NSCLC.","primaryOutcome":{"measure":"Progression-free Survival (PFS)","timeFrame":"Approximately 3 years","effectByArm":[{"arm":"Bevacizumab + Placebo","deltaMin":3.7,"sd":null},{"arm":"Bevacizumab + Erlotinib","deltaMin":4.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0006"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":21},"locations":{"siteCount":247,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Hong Kong","Israel","Italy","Mexico","Philippines","Romania","Singapore","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["24101054"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":63,"n":367},"commonTop":["Rash","Diarrhoea","Fatigue","Hypertension","Cough"]}}